rTMS as a Treatment of Visceral Pain Secondary to Malignancy

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the efficacy of rTMS over primary motor cortex in patients suffering from malignant visceral pain. Thirty four patients were included in the study. They are divided randomly into 2 groups using closed envelop as real rTMS group and sham group. Real rTMS over the hand area of motor cortex (20 Hz, 10 trains with inter train interval 30 second with total pulses 2000, intensity 80% of motor threshold) every day for ten consecutive days (5 days/week) and the coil elevated and angled away from the head as sham stimulation. Patients were evaluated by verbal descriptor scale (VDS), visual analog scale (VAS), and Hamilton rating scale for depression (HAM-D) at the baseline, after 1st, 5th, 10th session, 15 day and 1 month after end of sessions. Serum human dynorphin (Dyn) level was measured at baseline, 5th and 10th session.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02092805
Study type	Interventional
Source	Assiut University
Contact
Status	Completed
Phase	N/A
Start date	January 2010
Completion date	January 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05640115` - Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent	Early Phase 1
Recruiting	`NCT02891642` - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Completed	`NCT02282449` - Power Injectable Versus a Non-Power Injectable, Upper Arm, TIVAD for Chemotherapy	N/A
Completed	`NCT01212731` - Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
Completed	`NCT01199822` - Study of the Safety and Pharmacokinetics of IMC-3G3 in Japanese Patients With Solid Tumors	Phase 1
Recruiting	`NCT04122469` - The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease	N/A
Recruiting	`NCT03561727` - Risk Factors for Development of Incisional Hernia in Transverse Incisions	N/A
Terminated	`NCT03251924` - A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT03997968` - A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT00092222` - Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity	Phase 2
Recruiting	`NCT05770102` - DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition	Phase 2/Phase 3
Recruiting	`NCT05886764` - Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials	N/A
Not yet recruiting	`NCT05992363` - Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction	Phase 3
Recruiting	`NCT05761366` - Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor	Phase 2
Recruiting	`NCT04887545` - Immune- and Microenvironment- Proteogenomics Profiling for Classifying Lung Cancer Patients
Completed	`NCT03061955` - Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Completed	`NCT03909464` - Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy
Active, not recruiting	`NCT02649491` - Using an Electronic Nose to Predict Gastrointestinal Consequences of Pelvic Radiotherapy	N/A
Recruiting	`NCT02776995` - Tumor Monitoring Using Thermography During Radiation Therapy	N/A
Active, not recruiting	`NCT01242072` - Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies	Phase 1